Data and strategies on how to improve treatment adherence among hard-to-reach populations such as migrants, teenagers and children.
Encompassing eleven countries and slated for further expansion across the Asia Pacific region, the Trans-Pacific Partnership Agreement (TPP) is a regional trade agreement that will “set the standard for 21st-century trade agreements going forward.”
MSF will discuss the latest pricing trends from research conducted for its annual report on ARV prices, Untangling the Web, and will also announce the launch of a new database that serves as a how-to guide to oppose the granting of patents in the interest of public health and increased access to ARVs.
MSF releases first-of-its kind research from 23 countries affected by HIV about where we stand in terms of policies that support scale-up of HIV treatment.
Increased access to viral load monitoring can help people stay on antiretroviral combinations as long as possible, and help stave off resistance.
This session will highlight different responses to migration-related HIV challenges in four regions: sub-Saharan Africa, Asia, Eastern Europe as well as North America and Western Europe. The presenters will review…
Co-Chairs: Lennie Green, United States Rachel Baggaley, Switzerland 13:00 THPDE0301 Abstract Towards universal awareness of HIV status: a systematic review on uptake of home-based HIV testing in sub-Saharan Africa K….
Sustaining quality while scaling-up adolescent ART: findings from Zimbabwe’s largest adolescent cohort.
Co-Chairs: Christoforos Mallouris, Netherlands Jeffrey O’Malley, United States 16:30 MOAE0301 Impact of the Global Fund crisisS. Lynch, United States 16:45 MOAE0302 Abstract Sustainability of HIV programs: lessons learned from…
The scientific promise of beginning to reverse the epidemic through treatment as part of combination prevention is tempered by major funding gaps. However, now is the time to push forward with the most innovative treatment strategies, the most robust drug regimens, and enabling policies to make treatment more affordable.
Participants will leave this workshop with a better understanding on use of second-line ART in RLS, including the complex intersections between chronic HIV infection, long-term antiretroviral drug exposure and chronic-degenerative co-morbidities, and the latest scientific evidence on the use of ART as HIV prevention.
Overcoming Intellectual Property Barriers to Enable Access to Affordable ARVs: Pricing and Patent Toolkits and Sharing of Successful Strategies from Brazil, India and South Africa (THWS15)
Drawing on new tools and case studies from South Africa, Brazil, Argentina and India, this workshop will empower participants to identify IP barriers, assess impact on specific medical products, and design campaigns to implement legal and policy actions, including compulsory licenses, patent oppositions, and stricter patentability requirements.
The challenges and promise of scale-up of virological monitoring from a patient, health system, and market perspective.
Proposals for a Global Innovation System that Responds to Patients Needs and Ensures both Innovation and Access (SUSA39)
The challenges but also promising initiatives that could facilitate the development of affordable medical tools adapted to the needs of patients in resource-limited settings.